Evidence map›Paper›PMID 38692009›Full record

ArticleClinics (Sao Paulo, Brazil)2024

The mechanism of mitochondrial metabolic gene PMAIP1 involved in Alzheimer's disease process based on bioinformatics analysis and experimental validation.

Yingchun Ling, Lingmin Hu, Jie Chen, Mingyong Zhao, Xinyang Dai

Open access · goldAbstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yingchun LingDepartment of Clinical Laboratory, Shaoxing Seventh People's Hospital, Shaoxing, Zhejiang, China.
Lingmin HuDepartment of Clinical Laboratory, Shaoxing Seventh People's Hospital, Shaoxing, Zhejiang, China.
Jie ChenDepartment of Clinical Laboratory, Shaoxing Seventh People's Hospital, Shaoxing, Zhejiang, China.
Mingyong ZhaoDepartment of Geriatrics, Shaoxing Seventh People's Hospital, Shaoxing, Zhejiang, China.
Xinyang DaiDepartment of Clinical Laboratory, Shaoxing Seventh People's Hospital, Shaoxing, Zhejiang, China. Electronic address: Daixy850825@163.com.
Shaoxing People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study explored novel biomarkers that can affect the diagnosis and treatment in Alzheimer's Disease (AD) related to mitochondrial metabolism.

methodsThe authors obtained the brain tissue datasets for AD from the Gene Expression Omnibus (GEO) and downloaded the mitochondrial metabolism-related genes set from MitoCarta 3.0 for analysis. Differentially Expressed Genes (DEGs) were screened using the "limma" R package, and the biological functions and pathways were investigated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The LASSO algorithm was used to identify the candidate center genes and validated in the GSE97760 dataset. PMAIP1 with the highest diagnostic value was selected and its effect on the occurrence of AD by biological experiments.

resultsA sum of 364 DEGs and 50 hub genes were ascertained. GO and KEGG enrichment analysis demonstrated that DEGs were preponderantly associated with cell metabolism and apoptosis. Five genes most associated with AD as candidate central genes by LASSO algorithm analysis. Then, the expression level and specificity of candidate central genes were verified by GSE97760 dataset, which confirmed that PMAIP1 had a high diagnostic value. Finally, the regulatory effects of PMAIP1 on apoptosis and mitochondrial function were detected by siRNA, flow cytometry and Western blot. siRNA-PMAIP1 can alleviate mitochondrial dysfunction and inhibit cell apoptosis.

conclusionThis study identified biomarkers related to mitochondrial metabolism in AD and provided a theoretical basis for the diagnosis of AD. PMAIP1 was a potential candidate gene that may affect mitochondrial function in Hippocampal neuronal cells, and its mechanism deserves further study.

Indexed as

Alzheimer DiseaseComputational BiologyAlgorithmsApoptosisBiomarkersGene Expression ProfilingGene OntologyGenes, MitochondrialHumansMitochondriaMitochondrial ProteinsProto-Oncogene Proteins c-bcl-2BiomarkersMitochondrial ProteinsPMAIP1 protein, humanProto-Oncogene Proteins c-bcl-2Alzheimer's diseaseApoptosisBiomarkersMitochondrial Metabolism

Identifiers

PMID38692009
PMCPMC11070595
OpenAlexW4396529927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.